Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-23

Clinical Trial Update: A Trial to Evaluate the Pharmacokinetics and Safety of AVYCAZ(R) in Combination With Aztreonam [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating the pharmacokinetics and safety of AVYCAZ in combination with aztreonam has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avycaz (ceftazidime-avibactam)
  • Aztreonam (aztreonam)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-12-23